Smith & Nephew plc (SNN)

NYSE - NYSE Delayed Price. Currency in USD

Visitors trend2W10W9M

25.42

-0.38

(-1.47%)

At close: 04:00PM EDT

25.42

0.00

(0.00%)

After hours:

05:28PM EDT

Advertisement

Dividend
SNN announced a cash dividend of 0.288 with an ex-date of Oct. 5, 2023

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

Gap Down

View all chart patterns

Performance Outlook

Previous Close	25.80
Open	25.65
Bid	25.19 x 800
Ask	26.03 x 1100
Day's Range	25.42 - 25.68
52 Week Range	21.78 - 33.09
Volume	1,193,867
Avg. Volume	771,112

Market Cap	11.101B
Beta (5Y Monthly)	0.42
PE Ratio (TTM)	50.84
EPS (TTM)	0.50
Earnings Date	N/A
Forward Dividend & Yield	0.75 (2.91%)
Ex-Dividend Date	Oct 05, 2023
1y Target Est	34.33

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Near Fair Value

26% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SNN

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Smith & Nephew SNATS, Inc.
Analyst Report: Smith & Nephew plcSmith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Rating
Fair Value
Economic Moat
3 days agoMorningstar

All

Zacks
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Are Investors Undervaluing Preferred Bank (PFBC) Right Now?
  Zacks
- Are Investors Undervaluing M.D.C. (MDC) Right Now?
  Zacks
The Telegraph
This stock is in the last chance saloon – it needs to start delivering now
This column broke a few of its own rules when it identified Smith & Nephew, the medical devices company, as a potential post-lockdown turnaround candidate in March 2021 and has only had cause to regret it since.
Zacks
Should Value Investors Buy Koninklijke Philips (PHG) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Are Investors Undervaluing M.D.C. (MDC) Right Now?
  Zacks
- Should Value Investors Buy Wabash National (WNC) Stock?
  Zacks